Eli Lilly Gets Green Light For New Use Of Gemzar
The U.S. Food and Drug Administration has given Eli Lilly & Co. the go-ahead to use its drug Gemzar to treat women with recurrent ovarian cancer....To view the full article, register now.
Already a subscriber? Click here to view full article